Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency.

Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is the most frequently diagnosed mitochondrial beta-oxidation defect, and it is potentially fatal. Eighty percent of patients are homozygous for a common mutation, 985A-->G, and a further 18% have this mutation in only one disease allele. In addition, a large number of rare disease-causing mutations have been identified and characterized. There is no clear genotype-phenotype correlation. High 985A-->G carrier frequencies in populations of European descent and the usual avoidance of recurrent disease episodes by patients diagnosed with MCAD deficiency who comply with a simple dietary treatment suggest that MCAD deficiency is a candidate in prospective screening of newborns. Therefore, several such screening programs employing analysis of acylcarnitines in blood spots by tandem mass spectrometry (MS/MS) are currently used worldwide. No validation of this method by mutation analysis has yet been reported. We investigated for MCAD mutations in newborns from US populations who had been identified by prospective MS/MS-based screening of 930,078 blood spots. An MCAD-deficiency frequency of 1/15,001 was observed. Our mutation analysis shows that the MS/MS-based method is excellent for detection of MCAD deficiency but that the frequency of the 985A-->G mutant allele in newborns with a positive acylcarnitine profile is much lower than that observed in clinically affected patients. Our identification of a new mutation, 199T-->C, which has never been observed in patients with clinically manifested disease but was present in a large proportion of the acylcarnitine-positive samples, may explain this skewed ratio. Overexpression experiments showed that this is a mild folding mutation that exhibits decreased levels of enzyme activity only under stringent conditions. A carrier frequency of 1/500 in the general population makes the 199T-->C mutation one of the three most prevalent mutations in the enzymes of fatty-acid oxidation.

[1]  J. Ibdah,et al.  A Fetal Fatty-Acid Oxidation Disorder as a Cause of Liver Disease in Pregnant Women , 1999 .

[2]  D. Chace,et al.  Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry. , 1997, Clinical chemistry.

[3]  L. Bolund,et al.  Co-overexpression of bacterial GroESL chaperonins partly overcomes non-productive folding and tetramer assembly of E. coli-expressed human medium-chain acyl-CoA dehydrogenase (MCAD) carrying the prevalent disease-causing K304E mutation. , 1993, Biochimica et biophysica acta.

[4]  K. Tanaka,et al.  [Medium chain acyl-CoA dehydrogenase deficiency]. , 1988, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[5]  J. Leonard,et al.  Prospective surveillance study of medium chain acyl-CoA dehydrogenase deficiency in the UK , 1998, Archives of disease in childhood.

[6]  B. Wilcken,et al.  Neonatal symptoms in medium chain acyl coenzyme A dehydrogenase deficiency. , 1993, Archives of disease in childhood.

[7]  D. Kelly,et al.  Structural organization and regulatory regions of the human medium-chain acyl-CoA dehydrogenase gene. , 1992, Biochemistry.

[8]  R. Ponzone,et al.  Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: the prevalent mutation G985 (K304E) is subject to a strong founder effect from northwestern Europe. , 1993, Human heredity.

[9]  C. Zhou,et al.  Identification of a novel mutation in patients with medium-chain acyl-CoA dehydrogenase deficiency. , 2000, Molecular genetics and metabolism.

[10]  C. Roe,et al.  Medium-chain acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children. , 1994, The Journal of pediatrics.

[11]  E. Hoffman,et al.  Medium Chain Acyl-CoA Dehydrogenase Deficiency in Pennsylvania: Neonatal Screening Shows High Incidence and Unexpected Mutation Frequencies , 1995, Pediatric Research.

[12]  Zhifang,et al.  Molecular characterization of inherited medium-chain acyl-CoA dehydrogenase deficiency. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Wang,et al.  Crystal structures of medium-chain acyl-CoA dehydrogenase from pig liver mitochondria with and without substrate. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  L. Bolund,et al.  Effects of Two Mutations Detected in Medium Chain Acyl-CoA Dehydrogenase (MCAD)-deficient Patients on Folding, Oligomer Assembly, and Stability of MCAD Enzyme (*) , 1995, The Journal of Biological Chemistry.

[15]  L. Bolund,et al.  Specific diagnosis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in dried blood spots by a polymerase chain reaction (PCR) assay detecting a point-mutation (G985) in the MCAD gene. , 1991, Clinica chimica acta; international journal of clinical chemistry.

[16]  S. Packman,et al.  The molecular basis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in compound heterozygous patients: is there correlation between genotype and phenotype? , 1997, Human molecular genetics.

[17]  L. Bolund,et al.  A silent A to G mutation in exon 11 of the medium-chain acyl-CoA dehydrogenase (MCAD) gene. , 1993, Human molecular genetics.

[18]  H. Eiberg,et al.  A Survey of the Newborn Populations in Belgium, Germany, Poland, Czech Republic, Hungary, Bulgaria, Spain, Turkey, and Japan for the G985 Variant Allele with Haplotype Analysis at the Medium Chain Acyl-CoA , 1997, Pediatric Research.

[19]  C. Stanley,et al.  Medium-chain acyl-CoA dehydrogenase deficiency. Diagnosis by stable-isotope dilution measurement of urinary n-hexanoylglycine and 3-phenylpropionylglycine. , 1988 .

[20]  M. Morris,et al.  Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry , 1998, Archives of disease in childhood.

[21]  Y. T. Chen,et al.  Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood. , 1993, American journal of human genetics.

[22]  H. Eiberg,et al.  A survey of the newborn populations in Belgium, Germany, Poland, Czech Republic, Hungary, Bulgaria, Spain, Turkey, and Japan for the G985 variant allele with haplotype analysis at the medium chain Acyl-CoA dehydrogenase gene locus: clinical and evolutionary consideration. , 1997 .

[23]  F. Gabreëls,et al.  Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[24]  D. Hale,et al.  An acyl-coenzyme A dehydrogenase assay utilizing the ferricenium ion. , 1990, Analytical biochemistry.

[25]  R. Wanders,et al.  Heterozygosity for the Common LCHAD Mutation (1528G>C) Is Not a Major Cause of HELLP Syndrome and the Prevalence of the Mutation in the Dutch Population Is Low , 2000, Pediatric Research.

[26]  K. Tanaka,et al.  Molecular survey of a prevalent mutation, 985A-to-G transition, and identification of five infrequent mutations in the medium-chain Acyl-CoA dehydrogenase (MCAD) gene in 55 patients with MCAD deficiency. , 1991, American journal of human genetics.

[27]  L. Bolund,et al.  A rare disease-associated mutation in the medium-chain acyl-CoA dehydrogenase (MCAD) gene changes a conserved arginine, previously shown to be functionally essential in short-chain acyl-CoA dehydrogenase (SCAD). , 1993, American journal of human genetics.

[28]  P. Bross,et al.  Impaired folding and subunit assembly as disease mechanism: the example of medium-chain acyl-CoA dehydrogenase deficiency. , 1998, Progress in nucleic acid research and molecular biology.

[29]  D. Danks,et al.  Prevalence of K329E mutation in medium-chain acyl-CoA dehydrogenase gene determined from Guthrie cards , 1991, The Lancet.

[30]  W. Nyhan,et al.  An unusual presentation of medium-chain acyl coenzyme A dehydrogenase deficiency. , 1992, American journal of diseases of children.